A single center retrospective cohort study assessing the between Vedolizumab exposure and clearance with clinical outcomes in pediatric inflammatory bowel disease
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gastroenterology in conjunction with Digestive Disease Week 2020